Care pathway for necrotizing soft-tissue infections
Part of Bones, joints & muscles clinical trials.
This study looks at how patients with a serious skin infection called necrotizing soft-tissue infection (sometimes called flesh-eating disease) are cared for in a special treatment pathway. By joining, you help doctors learn more about this condition and how to improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or your child must have a suspected or confirmed necrotizing soft-tissue infection (a fast-spreading, serious skin and tissue infection).
- People of any age, including adults and children, can take part.
- You or your legal guardian must agree to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two wound care methods after emergency surgery for a serious skin infection. One method uses a standard wound vacuum, and the other uses a wound vacuum that also irrigates (rinses) the wound to see if it helps with healing.
This trial studies a rare but serious infection called necrotizing soft-tissue infection (NSTI), which destroys tissue quickly. It looks at how patients are treated in hospitals across Europe to improve care.
This study looks at what factors are linked to higher risk of death in patients hospitalized with a severe, flesh-eating infection called necrotizing soft tissue infection (NSTI). It aims to help doctors better identify and treat these dangerous infections.
This trial tests whether adding hyperbaric oxygen therapy to standard care helps adults with a serious soft-tissue infection. It could improve healing and reduce complications.
This trial tests whether hyperbaric oxygen (breathing pure oxygen in a pressurized room) helps treat necrotizing fasciitis and similar severe soft tissue infections. It aims to improve healing and outcomes for people with these serious infections.
This study tests two special wound dressings (Cytal® Wound Matrix and MicroMatrix®) to help heal wounds caused by a serious flesh-eating infection called necrotizing fasciitis. The goal is to see if these dressings improve healing and reduce the need for more surgeries.
Hear when a new Necrotizing Soft-tissue Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.